Immune Appoints Cameron Durrant, MD, MBA to Board of Directors
July 14, 2014 02:30 ET
|
Immune Pharmaceuticals Inc.
NEW YORK and HERZLIYA-PITUACH, Israel, July 14, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) ("Immune" or "the Company") appointed Dr. Cameron Durrant as new...
IMMUNE Partners With Patient Community Group LYFEBULB
June 25, 2014 02:30 ET
|
Immune Pharmaceuticals Inc.
NEW YORK, June 25, 2014 (GLOBE NEWSWIRE) -- Lyfebulb, an organization dedicated to helping people achieve their optimal lifestyle by addressing general and chronic health concerns, and Immune...
Immune Appoints Gad Berdugo to Board of Directors and Karin Hehenberger, M.D., Ph.D to Senior Vice President
June 06, 2014 02:30 ET
|
Immune Pharmaceuticals Inc.
NEW YORK and HERZLIYA-PITUACH, Israel, June 6, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) ("Immune" or "the Company") appointed Mr. Gad Berdugo as new independent...
Immune Pharmaceuticals Announces First Quarter 2014 Financial Results
May 21, 2014 02:30 ET
|
Immune Pharmaceuticals Inc.
NEW YORK and HERZLIYA-PITUACH, Israel, May 21, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) and (Nasdaq:IMNP) ("Immune" or "the Company") announced today its financial results for...
Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET
May 05, 2014 02:30 ET
|
Immune Pharmaceuticals Inc.
NEW YORK and HERZLIYA-PITUACH, Israel, May 5, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX: IMNP) (Nasdaq:IMNP) ("Immune" or the "Company") announces its clinical trial and...
Immune Pharmaceuticals Announces Company Highlights and Reports Full Fiscal Year 2013 Financial Results
April 10, 2014 02:30 ET
|
Immune Pharmaceuticals Inc.
NEW YORK and HERZLIYA-PITUACH, Israel, April 10, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) and (Nasdaq:IMNP) ("Immune" or "the Company") announced today company highlights and...
Immune CEO Announces New Operational Leadership Team
April 02, 2014 02:30 ET
|
Immune Pharmaceuticals Inc.
NEW YORK and HERZLIYA, Israel, April 2, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) announced today the addition of two new senior members to its management...
Immune Pharmaceuticals Announces $11.7 Million Private Placement Financing
March 10, 2014 00:01 ET
|
Immune Pharmaceuticals Inc.
NEW YORK and HERZLIYA, Israel, March 10, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) announced today that it has entered into a definitive agreement with investors...